(Q40583188)

21 September 2017

Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels (English)

1 reference

21 September 2017

1 reference

Jin-Ping Zhang

1

1 reference

21 September 2017

Na Wang

2

1 reference

21 September 2017

Xiao-Yan Xing

3

1 reference

21 September 2017

Zhao-Jun Yang

4

1 reference

21 September 2017

Xin Wang

5

1 reference

21 September 2017

Wen-Ying Yang

6

1 reference

21 September 2017

29 August 2015

1 reference

21 September 2017

1 reference

21 September 2017

8

1 reference

21 September 2017

4

1 reference

21 September 2017

559-567

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Prevalence and control of diabetes in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

21 January 2018

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12337

21 January 2018

Identifiers

DOI

10.1111/1753-0407.12337

1 reference

21 September 2017

1 reference